Androgen deprivation therapy in patients with prostate cancer and changes in bone mineral density.

被引:0
|
作者
Alferos, MG
Yaturu, S
机构
[1] OvertonBrooks VAMC, Shreveport, LA USA
[2] LSUHSC, Shreveport, LA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S243 / S243
页数:1
相关论文
共 50 条
  • [31] Contemporary analysis of bone mineral density in men initiating androgen deprivation therapy for prostate cancer.
    Hu, Jason
    Aprikian, Armen G.
    Vanhuyse, Marie
    Dragomir, Alice
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [32] Effects of alendronate on bone mineral density in men with prostate cancer treated with androgen deprivation therapy.
    Bruder, JM
    Katselnik, D
    Wing, N
    Ma, JZ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S217 - S217
  • [33] Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer COMMENT
    Singer, Frederick R.
    [J]. JOURNAL OF UROLOGY, 2009, 182 (06): : 2676 - 2676
  • [34] Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer
    Morgans, A. K.
    Hancock, M. L.
    Barnette, G.
    Steiner, M. S.
    Morton, R. A.
    Smith, M. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [35] Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer
    Panju, Abbas H.
    Breunis, Henriette
    Cheung, Angela M.
    Leach, Marc
    Fleshner, Neil
    Warde, Padraig
    Duff-Canning, Sarah
    Krahn, Murray
    Naglie, Gary
    Tannock, Ian
    Tomlinson, George
    Alibhai, Shabbir M. H.
    [J]. BJU INTERNATIONAL, 2009, 103 (06) : 753 - 757
  • [36] Racial Differences in Bone Mineral Density and Fractures in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Morgans, Alicia K.
    Hancock, Michael L.
    Barnette, K. Gary
    Steiner, Mitchell S.
    Morton, Ronald A.
    Smith, Matthew R.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (03): : 889 - 893
  • [37] Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy
    Dalla Via, Jack
    Daly, Robin M.
    Owen, Patrick J.
    Mundell, Niamh L.
    Rantalainen, Timo
    Fraser, Steve F.
    [J]. BONE, 2019, 127 : 367 - 375
  • [38] Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab
    Miyazawa, Yoshiyuki
    Sekine, Yoshitaka
    Syuto, Takahiro
    Nomura, Masashi
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Ito, Kazuto
    Suzuki, Kazuhiro
    [J]. ANTICANCER RESEARCH, 2017, 37 (07) : 3667 - 3671
  • [39] METABOLIC CHANGES IN PATIENTS WITH PROSTATE CANCER WITH ANDROGEN DEPRIVATION THERAPY
    Peshkov, Maxim N.
    Peshkova, Galina P.
    Reshetov, Igor, V
    [J]. DIABETES MELLITUS, 2020, 23 (02): : 192 - 200
  • [40] The Clinical Significance of Bone Mineral Density Changes Following Long Term Androgen Deprivation Therapy in Prostate Cancer Patients Enrolled in the PCS V Trial
    Vaughan, R.
    Tsui, J. M. G.
    Kucharczyk, M. J.
    Nabid, A.
    Bettahar, R.
    Vincent, L. S.
    Martin, A. G.
    Jolicoeur, M.
    Yassa, M.
    Barkati, M.
    Igidbashian, L.
    Bahoric, B.
    Archambault, R.
    Villeneuve, H.
    Mohiuddin, M.
    Niazi, T. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E312 - E313